We further confirmed the role of the ARHGAP5, ARHGAP11A, and ARHGAP12 in immunotherapy by calculating the degree of infiltration of 28 immune cell types in high or low ARHGAP5, ARHGAP11A, or ARHGAP12 in PAAD samples. Here, ARHGAP5 is linked to pancreatic adenocarcinoma.